Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $0.28 |
Close | - |
Volume / Avg. | 237.87K / 1.23M |
Day Range | $0.27 - $0.28 |
52 Wk Range | 0.25 - 6.79 |
Market Cap | $18.12M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 5.65% |
Days to Cover | 3.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
Lyra Therapeutics has a consensus price target of $8.38.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.27675 last updated September 23, 2024 at 2:35 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.